Merck places children's HIV drug in shared non-profit patent pool

February 24, 2015 8:00 AM

5 0

LONDON (Reuters) - U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap pediatric formulations for use in poor countries.

The non-profit Medicines Patent Pool (MPP), which aims to persuade leading drug companies to share rights to their products with generic manufacturers, said on Tuesday the deal for Merck's raltegravir would add to the treatment arsenal.

Also read: Microsoft Closes Acquisition of LinkedIn

Read more

To category page

Loading...